Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Cancer Chemotherapy and Pharmacology
|
December 29, 2000
Oral uracil and Ftorafur plus leucovorin: pharmacokinetics and toxicity in patients with metastatic cancer
D H Ho, W Covington, N Brown, et al.
Cancer
|
August 10, 2000
Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences
J S Mandelblatt, J Hadley, J F Kerner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 1996
Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicity
N J Meropol, M Porter, L E Blumenson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 3, 2012
Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer
C Aggarwal, N J Meropol, C J Punt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2001
The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma
M von Mehren, P Arlen, J Gulley, et al.
American Journal of Surgery
|
September 1, 1996
Granulocyte-macrophage colony-stimulating factor as infection prophylaxis in high-risk oncologic surgery
N J Meropol, N J Petrelli, B J Lipman, et al.
British Journal of Cancer
|
March 11, 2015
Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours
A J Zurita, M Khajavi, H-K Wu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 14, 2009
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
S J Cohen, C J A Punt, N Iannotti, et al.
European Journal of Cancer Care
|
January 29, 2014
Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers
S Manne, D Kashy, T Albrecht, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Cancer Chemotherapy and Pharmacology
|
December 29, 2000
Oral uracil and Ftorafur plus leucovorin: pharmacokinetics and toxicity in patients with metastatic cancer
D H Ho, W Covington, N Brown, et al.
Cancer
|
August 10, 2000
Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences
J S Mandelblatt, J Hadley, J F Kerner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 1996
Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicity
N J Meropol, M Porter, L E Blumenson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 3, 2012
Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer
C Aggarwal, N J Meropol, C J Punt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2001
The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma
M von Mehren, P Arlen, J Gulley, et al.
American Journal of Surgery
|
September 1, 1996
Granulocyte-macrophage colony-stimulating factor as infection prophylaxis in high-risk oncologic surgery
N J Meropol, N J Petrelli, B J Lipman, et al.
British Journal of Cancer
|
March 11, 2015
Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours
A J Zurita, M Khajavi, H-K Wu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 14, 2009
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
S J Cohen, C J A Punt, N Iannotti, et al.
European Journal of Cancer Care
|
January 29, 2014
Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers
S Manne, D Kashy, T Albrecht, et al.
Page
of 7